To include your compound in the COVID-19 Resource Center, submit it here.

Apellis raises $60M in series E

Autoimmune company Apellis Pharmaceuticals Inc. (Crestwood, Ky.) raised $60 million in a series

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE